Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Allergy Therapeutics"
Count: 40
Selected: 0
| NCT ID | Title |
|---|
| NCT05540717 | Efficacy and Safety of PQ Grass in Subjects With Seasonal Allergic Rhinitis and/or Rhinoconjunctivitis Induced by Grass Pollen | ||
| NCT05476497 | Study to Evaluate Safety and Preliminary Efficacy of VLP Peanut, for the Treatment of Allergy to Peanuts, in Healthy and Peanut Allergic Adults | ||
| NCT05455749 | Effect of holoBLG on Cat Allergic Patients | ||
| NCT04687059 | An Exploratory Study of PQ Grass 27600 SU | ||
| NCT05186025 | Tyrosine Allergoid Paediatric and Adult Study | ||
| NCT00109759 | Evaluation of Safety and Tolerability of Tyrosine Adsorbed Ragweed Pollen Allergoid With MPL (Monophosphoryl Lipid A) | ||
| NCT00133146 | Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Grass Pollen Allergy Vaccine | ||
| NCT00258635 | Investigation of Safety+Efficacy of Different Doses of RagweedMATAMPL;Assessment of Residual Allergenicity Using Skin Prick Test | ||
| NCT00133159 | Different Doses of Tyrosine Adsorbed Grass Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Grass Pollen | ||
| NCT00118612 | Different Doses of Tyrosine Adsorbed Tree Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Tree Pollen | ||
| NCT04389034 | Influence of Specific Immunotherapy With Pollinex Quattro (Tree-/Grass Pollen) on Allergen-specific Immunoglobulin E (IgE) Levels | ||
| NCT02582073 | Dose Selection Study of Efficacy and Safety of Different Doses of Grass MATA MPL and Grass MATA Using mEECs™ | ||
| NCT00387478 | Investigation of Efficacy and Safety of Tree MATAMPL,Tree MATA, and Placebo in Patients With Birch-Induced Seasonal Allergic Rhinitis | ||
| NCT03931993 | A Study of Tolerability and Safety of a New Cumulative Dose of Grass MATA MPL | ||
| NCT02557633 | A Study of Tolerability and Safety of Two New Doses of Grass MATA MPL | ||
| NCT00423787 | Efficacy and Safety/Tolerability of Ragweed MATA MPL | ||
| NCT00414141 | Efficacy and Safety/Tolerability of Grass MATA MPL | ||
| NCT00325338 | Follow-up Investigation of Efficacy of Ragweed MATAMPL,and Placebo in Patients With Ragweed-induced Seasonal Allergic Rhinitis | ||
| NCT00241410 | Safety, Immunological Effect and Efficacy of the Combined Application of MPL and Grass Pollen Allergen | ||
| NCT00118625 | Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Tree Pollen Allergy Vaccine | ||
| NCT00116285 | Assessment of Residual Allergenicity of Ragweed Pollen Allergoid With Monophosphoryl Lipid A (MPL) Using Skin Prick Testing | ||
| NCT00113750 | Induction of Immunogenicity With Different Doses of TreeMATA in Subjects Allergic to Tree Pollen | ||
| NCT00110786 | Investigation of Efficacy and Safety of Ragweed MATAMPL, Pollinex-R and Placebo in Patients With Ragweed Allergy | ||
| NCT00107705 | Assessment of Residual Allergenicity of Tree (Birch, Hazel, and Alder) Pollen Allergoid Using Skin Prick Testing | ||
| NCT00104377 | Induction of Immunogenicity With Different Doses of Grass MATA in Subjects Allergic to Grass and Rye Pollen | ||
| NCT00104390 | Assessment of Residual Allergenicity of Grass/Rye Pollen Allergoid Using Skin Prick Testing | ||
| NCT00417573 | Efficacy of IgIv in Patients With IgG Subclass Deficiency and Recurrent Infections | ||
| NCT00850668 | Peanut Allergy Vaccine Study in Healthy and Peanut-allergic Adults | ||
| NCT02210325 | Efficacy and Safety Study of Oral Solithromycin Compared to Intramuscular Ceftriaxone Plus Oral Azithromycin in the Treatment of Patients With Gonorrhea | ||
| NCT01292070 | Safety Evaluation of an Experimental Treatment, Intradermal Human Fcγ1-Fel d1 Fusion Protein (GFD), for Cat Allergy | ||
| NCT01220531 | Thymus Transplantation Safety-Efficacy | ||
| NCT00579709 | Thymus Transplantation With Immunosuppression | ||
| NCT00849888 | Serum-Free Thymus Transplantation in DiGeorge Anomaly | ||
| NCT00579527 | Phase I/II Thymus Transplantation With Immunosuppression #950 | ||
| NCT00576836 | Thymus Transplantation Dose in DiGeorge #932 | ||
| NCT00576407 | Thymus Transplantation in DiGeorge Syndrome #668 | ||
| NCT01346150 | Patients Treated for SCID (1968-Present) | ||
| NCT02064933 | Patients Treated for Wiskott-Aldrich Syndrome (WAS) Since 1990 | ||
| NCT02082353 | Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995 | ||
| NCT02042248 | A Phase I Study to Evaluate the Immunologic Response and Virologic Impact of AGS-004 |
